Fish oil prevents 60% of Alzheimer’s disease

The Principle: Most Disease Is Preventable

One of the central themes of the Frequency Research Foundation’s work is that over 50% of disease is unnecessary. Simple nutritional strategies can prevent the majority of chronic conditions in most people. Fish oil and Alzheimer’s disease are perhaps the clearest illustration of this principle.

A landmark prospective study by Morris et al. (2003), published in Archives of Neurology, demonstrated that people who consumed fish once per week had a 60% lower risk of developing Alzheimer’s disease. The protective effect was specifically attributed to docosahexaenoic acid (DHA), not to omega-3s in general.

We covered the epidemiological findings of this study in detail in our companion article Alzheimer’s Disease: 60% Reduction in Risk From Eating Fish Once a Week!. This article focuses on the deeper question: why does fish oil protect the brain, and how can you use this knowledge to maximize your protection?

DHA: The Brain’s Essential Building Block

To understand why fish oil prevents Alzheimer’s disease, you need to understand what DHA does in the brain. It is not simply a nutrient that supports general health. DHA is a structural component of the brain itself.

The Numbers Are Striking

DHA (docosahexaenoic acid) comprises approximately 40% of the polyunsaturated fatty acids in the brain. It is the most abundant omega-3 fatty acid in neural tissue. In the cerebral cortex — the brain region responsible for memory, attention, thought, language, and consciousness — DHA concentrations are among the highest of any tissue in the body. The retina of the eye, which is an extension of the brain, contains even higher concentrations.

The brain does not just use DHA. The brain is built from DHA. When DHA levels are insufficient, the brain literally lacks the raw material it needs to maintain its structure and function.

What DHA Does at the Cellular Level

Every neuron in the brain is surrounded by a cell membrane made primarily of fatty acids. The composition of this membrane determines how well the neuron functions. DHA-rich membranes are more fluid, more flexible, and more efficient at transmitting signals between neurons.

When DHA is insufficient, the body substitutes other fatty acids — typically omega-6 fatty acids like arachidonic acid — into the membrane. These substitutes create membranes that are stiffer, less efficient at signal transmission, and more prone to inflammatory signaling. Over time, this degradation in membrane quality contributes to impaired cognitive function and increased vulnerability to neurodegenerative processes.

DHA also plays critical roles beyond structural support. It modulates gene expression in neurons, influencing which proteins are produced and in what quantities. It supports synaptic plasticity, the brain’s ability to form new connections and adapt — the biological basis of learning and memory. DHA is a precursor to neuroprotectin D1 (NPD1), a powerful anti-inflammatory and neuroprotective molecule produced specifically in the brain. It supports the production of brain-derived neurotrophic factor (BDNF), often called “fertilizer for the brain,” which promotes neuronal growth and survival.

How DHA Deficiency Drives Alzheimer’s Pathology

The connection between fish oil and Alzheimer’s disease becomes clearer when you understand what happens in the brain when DHA is chronically low.

Neuroinflammation Accelerates

Without adequate DHA, the brain cannot produce sufficient neuroprotectin D1 (NPD1) and other specialized pro-resolving mediators (SPMs). These molecules are the brain’s primary mechanism for shutting down inflammatory processes after they have served their purpose. Without them, inflammation becomes chronic — and chronic neuroinflammation is now recognized as one of the primary drivers of Alzheimer’s disease progression.

This connects directly to our broader work on inflammation. Our article Eliminating Inflammation Is a Top Priority for Disease Prevention covers why managing inflammation is the foundational strategy for preventing chronic disease, including Alzheimer’s.

Amyloid Clearance Is Impaired

Emerging research suggests that DHA supports the brain’s ability to clear amyloid beta — the toxic protein fragments that accumulate into the characteristic plaques of Alzheimer’s disease. DHA appears to promote amyloid clearance through multiple mechanisms, including supporting microglial function (the brain’s immune cells that engulf and remove debris) and maintaining the integrity of the blood-brain barrier, which plays a role in amyloid transport out of the brain.

When DHA is insufficient, these clearance mechanisms become less efficient, allowing amyloid to accumulate faster than the brain can remove it.

Synaptic Function Deteriorates

The earliest cognitive symptoms of Alzheimer’s — difficulty forming new memories, word-finding problems, impaired reasoning — correlate with synaptic loss rather than neuronal death. DHA is essential for synaptic membrane integrity and neurotransmitter release. Chronic DHA deficiency accelerates synaptic deterioration, which accelerates cognitive decline.

2025 Update: 20 Years of Mechanistic Discoveries

Since we first published this article in 2003, the science explaining how fish oil prevents Alzheimer’s disease has advanced dramatically. What was once an epidemiological observation (fish eaters get less Alzheimer’s) is now supported by detailed mechanistic understanding at the molecular, cellular, and brain-systems level.

The Neuroprotectin D1 Discovery

One of the most significant discoveries was the identification of neuroprotectin D1 (NPD1), a DHA-derived molecule that is potently anti-inflammatory and neuroprotective. Research led by Dr. Nicolas Bazan at Louisiana State University demonstrated that NPD1 is reduced in Alzheimer’s disease brains and that supplementing DHA restores its production. NPD1 has been shown to reduce amyloid beta secretion, counteract inflammatory signaling, and protect neurons from programmed cell death.

Blood Levels Predict Brain Health

Multiple studies have now demonstrated that blood levels of DHA predict brain outcomes years later. The Framingham Heart Study found that participants with the lowest DHA levels had significantly smaller brain volumes and worse cognitive performance. The Women’s Health Initiative Memory Study found that women with the highest omega-3 blood levels had larger brain volumes eight years later — particularly in the hippocampus, the memory center that is first affected in Alzheimer’s.

The Omega-3 Index

Researchers have developed the Omega-3 Index — a blood test measuring the percentage of EPA and DHA in red blood cell membranes — as a biomarker for both cardiovascular and brain health. An Omega-3 Index of 8% or above is considered protective, while levels below 4% indicate high risk. Studies estimate that a large majority of Americans have levels below the protective threshold, suggesting widespread insufficiency that may be contributing to neurodegenerative disease rates.

Clinical Trial Evidence

While observational studies consistently show that fish oil is protective, clinical trials of omega-3 supplementation in people who already have diagnosed Alzheimer’s have shown more modest results. This is an important nuance: DHA appears to be most powerful as a preventive strategy. Once significant neurodegeneration has occurred, DHA alone cannot reverse the damage. This finding reinforces the importance of early and sustained DHA intake throughout life — and of combining nutritional strategies with other approaches, including frequency therapy, for people who are already experiencing cognitive decline.

Choosing the Right Fish Oil: Quality Matters

Not all fish oil supplements are created equal. The difference between a high-quality product and a low-quality one can mean the difference between meaningful neuroprotection and wasted money.

What to Look For

The most important factor is DHA content per serving. Many supplements advertise total omega-3 content, which includes EPA and other fatty acids. For brain protection, you want at least 500-1000 mg of DHA specifically per daily dose. The molecular form matters as well. Triglyceride form fish oil has significantly better absorption than ethyl ester form. Some products specify this on the label; if they do not, it is likely ethyl ester.

Purity is essential. Fish can accumulate mercury, PCBs, dioxins, and other contaminants. Quality fish oil undergoes molecular distillation to remove these toxins. Look for products with third-party testing certifications from organizations like IFOS (International Fish Oil Standards).

Freshness matters more than most people realize. Omega-3 fatty acids are highly susceptible to oxidation. Rancid fish oil is not only ineffective but potentially harmful, as oxidized lipids promote rather than reduce inflammation. If your fish oil smells strongly or gives you “fish burps,” it may be oxidized.

Algal DHA for Vegetarians

For those who cannot or choose not to consume fish oil, algae-derived DHA supplements provide the same molecule from the original source in the marine food chain. Fish accumulate DHA by eating algae and organisms that eat algae. Cutting out the fish and going directly to algal DHA is a viable and effective alternative.

How Fish Oil and Frequency Therapy Work Together

The research is clear that fish oil and Alzheimer’s disease prevention are strongly linked. But nutrition alone may not be sufficient for everyone, particularly for people with existing cognitive decline, chronic infections, or other compounding risk factors.

This is where frequency therapy provides a complementary layer of protection and treatment.

DHA provides the structural raw material for healthy neuronal membranes. Frequency therapy, particularly 40 Hz gamma stimulation, activates the brain’s natural mechanisms for using those membranes effectively — restoring the gamma oscillations that Alzheimer’s patients lose. Our articles on 40 Hz gamma stimulation for Alzheimer’s and replacing the missing gamma frequency cover this science in detail.

Fish oil’s anti-inflammatory DHA derivatives (NPD1 and SPMs) work through biochemical pathways. Anti-inflammatory frequency protocols work through electromagnetic pathways. Together, they address neuroinflammation from two directions simultaneously.

DHA supports the immune cells (microglia) that clear amyloid plaques. Frequency therapy may help these same cells function more effectively, as the 40 Hz gamma research from MIT has demonstrated. Fish oil creates the optimal biological foundation on which frequency therapy can produce its best results.

For the complete picture of how nutrition, frequency therapy, infection management, and brain wave restoration work together, read our complete guide to Alzheimer’s disease and frequency therapy.

Looking for a comprehensive approach that combines nutritional optimization with frequency therapy? Dr. Jeff Sutherland offers personalized paid consultations to evaluate your situation and develop a multi-layered protocol for brain protection. Book Your Consultation

Frequently Asked Questions

How much fish oil should I take to prevent Alzheimer’s disease?

Based on the research, aim for at least 500-1000 mg of DHA (not total omega-3) per day. The Morris et al. study found that even one serving of fish per week provided significant protection, but higher DHA intake through supplementation offers more consistent and reliable brain levels. Look for triglyceride-form fish oil with third-party purity testing, and check the DHA content specifically on the supplement facts label.

Is it better to eat fish or take fish oil supplements?

Both are effective. Whole fish provides DHA along with complete protein, selenium, vitamin D, and other brain-supporting nutrients. Fish oil supplements provide more concentrated and consistent DHA dosing. The ideal approach is regular fatty fish consumption (salmon, sardines, mackerel) supplemented with high-quality fish oil to ensure adequate daily DHA intake. For those who do not eat fish, algae-derived DHA supplements are an effective alternative.

Can fish oil reverse Alzheimer’s disease once it has started?

Clinical trials suggest that DHA is most powerful as a preventive strategy. Once significant neurodegeneration has occurred, fish oil alone has shown modest results in clinical trials. This is why early and sustained DHA intake throughout life is important, and why people already experiencing cognitive decline may benefit from combining fish oil with other interventions — including frequency therapy — that address multiple aspects of the disease simultaneously. A consultation with Dr. Jeff Sutherland can help determine the right combination for your situation.

What is the difference between DHA and EPA?

DHA (docosahexaenoic acid) is the omega-3 that concentrates in brain tissue and is essential for neuronal membrane structure and function. EPA (eicosapentaenoic acid) is primarily an anti-inflammatory omega-3 that benefits the cardiovascular system and body-wide inflammation. For Alzheimer’s prevention specifically, DHA is the critical component — the Morris et al. study found that DHA intake was associated with reduced Alzheimer’s risk while EPA was not. For overall health, both are beneficial.

My Omega-3 Index is low — how long does it take to raise it?

Research indicates that consistent fish oil supplementation typically takes 8-12 weeks to significantly change the Omega-3 Index, as it reflects the fatty acid composition of red blood cell membranes over the cells’ approximately 120-day lifespan. Higher doses will raise levels faster, but gradual, sustained supplementation is more important than short-term loading. Retesting after 3 months of consistent supplementation can confirm improvement.

Take the Next Step

Fish oil prevents Alzheimer’s disease — the evidence is clear and has been consistent for over two decades. But prevention is most effective as part of a comprehensive strategy that also addresses infections, inflammation, environmental toxins, and disrupted brain wave patterns.

A consultation with Dr. Jeff Sutherland can help you build that comprehensive approach, combining nutritional optimization with personalized frequency protocols tailored to your individual risk profile.

Book Your Consultation with Dr. Jeff Sutherland

This article is part of our comprehensive Alzheimer’s resource library. Fish oil is one of the most evidence-based nutritional strategies for Alzheimer’s prevention. Read our complete guide to Alzheimer’s disease and frequency therapy for the full scope of research, from 40 Hz gamma science to infection management and personalized protocols.

© Frequency Research Foundation. This content is for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals regarding medical conditions and before starting any supplementation program.

Eliminating inflammation is a top priority for disease prevention

The Root of All Evil

In 2003, Professor Emad El-Omar, a gastroenterologist at the University of Aberdeen, made a statement that captured what researchers across multiple fields were beginning to understand: “I personally believe that chronic inflammation is the root of all evil.”

He was not exaggerating. Over the previous decade, inflammation had been implicated as both a cause and an accelerating factor in a growing number of widespread and seemingly unrelated diseases — atherosclerosis, Alzheimer’s disease, and multiple types of cancer among them.

When we published this article in 2003, we made two core assertions. First, that eliminating inflammation should be the top priority for anyone serious about disease prevention. Second, that applying the right electromagnetic frequencies to the organisms driving inflammation could not only prevent infectious disease but radically reduce the risk of chronic diseases.

Twenty-two years later, both assertions have been validated by an enormous body of research. Chronic inflammation is now recognized as the central mechanism in virtually every major chronic disease. And frequency-based approaches to managing inflammation are gaining scientific support.

What Is Chronic Inflammation — And Why Is It Different?

Inflammation itself is not the enemy. Acute inflammation is the body’s essential first line of defense. When a finger catches the sharp edge of an envelope, when pollen is inhaled, when a virus finds a new host — the body responds through inflammation. This process involves a molecular cascade orchestrated by chemokines and other biochemicals of the innate immune system, eventually engaging immune cells and antigens involved in adaptive immunity.

Under normal circumstances, this response resolves quickly. The threat is eliminated, the inflammatory signals shut down, the tissue heals. End of story.

The problem begins when inflammation does not resolve. When the trigger persists — a chronic infection the immune system cannot fully clear, ongoing exposure to environmental toxins, sustained psychological stress, or a diet that continuously promotes inflammatory signaling — the inflammatory response becomes chronic. It shifts from being a protective, short-term response to being a destructive, long-term state.

Chronic inflammation is fundamentally different from acute inflammation in its effects. Acute inflammation heals. Chronic inflammation destroys. It damages blood vessel walls, contributing to atherosclerosis and heart disease. It disrupts cellular DNA repair mechanisms, promoting cancer development. It degrades neuronal connections in the brain, driving Alzheimer’s disease and other neurodegenerative conditions. It impairs insulin signaling, contributing to type 2 diabetes. It erodes joint tissue, driving arthritis and chronic pain.

The insidious aspect of chronic inflammation is that it often operates silently. There may be no obvious symptoms — no redness, no swelling, no fever. The damage accumulates gradually over years and decades, only becoming apparent when it manifests as a diagnosed disease.

The Inflammation-Alzheimer’s Connection

Of all the diseases linked to chronic inflammation, the connection to Alzheimer’s disease has become one of the most thoroughly documented. This is directly relevant to our work at the Frequency Research Foundation.

Neuroinflammation Drives the Disease

Chronic inflammation in the brain — neuroinflammation — is now recognized not merely as a secondary effect of Alzheimer’s disease but as a primary driver of its progression. The brain’s immune cells, called microglia, become chronically activated and shift from their protective role (clearing debris and pathogens) to a destructive state (releasing inflammatory molecules that damage healthy neurons).

This chronic microglial activation is triggered and sustained by multiple factors. Chronic infections in the brain, including herpes simplex virus, drive ongoing immune activation. Our article Alzheimer’s and Herpes Simplex Virus details how HSV-1 DNA is found in 90% of Alzheimer’s plaques. Environmental toxins like aluminum nanoparticles and glyphosate trigger persistent inflammatory responses in brain tissue. Our articles on nano aluminum creating chronic infections and glyphosate increasing Alzheimer’s risk explore these pathways. Elevated homocysteine promotes vascular inflammation that extends to the brain. Homocysteine, heart disease, and Alzheimer disease covers this biomarker in detail. Mycoplasma and other chronic infections that cross the blood-brain barrier create ongoing inflammatory burden. Our mycoplasma research is documented in Mycoplasma: A Key Component in Lyme and Other Diseases.

Every one of these inflammatory triggers is addressed in our complete guide to Alzheimer’s disease and frequency therapy.

The Amyloid-Inflammation Cycle

Recent research has revealed that the relationship between inflammation and Alzheimer’s is cyclical and self-reinforcing. Chronic infections and toxins trigger neuroinflammation. The inflamed brain produces amyloid beta as part of its antimicrobial defense response. The accumulating amyloid itself triggers further inflammatory signaling. This additional inflammation causes more neuronal damage and more amyloid production. The cycle accelerates over years until clinical symptoms emerge.

Breaking this cycle — by eliminating the infections driving inflammation, removing the toxic triggers, and calming the inflammatory response itself — is the most promising strategy for both preventing and slowing Alzheimer’s disease. This is exactly what a comprehensive frequency therapy approach aims to do.

How the Science Has Evolved Since 2003

When we published this article, the connection between chronic inflammation and disease was a growing area of research but not yet mainstream. Today, it is arguably the most studied topic in chronic disease biology.

Inflammation Biomarkers Are Now Standard

C-reactive protein (CRP), a blood marker of systemic inflammation, is now routinely measured in cardiovascular risk assessment. High-sensitivity CRP testing can detect low-grade chronic inflammation that standard tests miss. Our article Vitamin C Supplements Lower C-Reactive Protein Levels covers a simple, evidence-based strategy for reducing this critical biomarker. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) are now well-characterized inflammatory mediators linked to multiple chronic diseases. These were relatively obscure in 2003; today, they are the targets of billion-dollar drug development programs.

The Gut-Brain Inflammation Axis

One of the most significant discoveries since 2003 is the gut-brain axis — the bidirectional communication system between the gut microbiome and the brain. Gut inflammation, driven by dietary factors, infections, and environmental toxins like glyphosate, can trigger neuroinflammation through multiple pathways including the vagus nerve, circulating inflammatory cytokines, and a compromised intestinal barrier (“leaky gut”).

This discovery has profound implications. It means that inflammation in the gut — caused by poor diet, glyphosate-contaminated food, chronic gut infections, or dysbiosis — can directly contribute to Alzheimer’s disease and other neurodegenerative conditions without the inflammatory trigger ever being present in the brain itself. Managing gut health is therefore an integral part of managing brain health.

Anti-Inflammatory Nutrition Has Been Validated

The role of diet in managing chronic inflammation has been extensively documented since 2003. The Mediterranean diet, rich in olive oil, fish, fruits, vegetables, and moderate wine consumption, has been shown to reduce inflammatory markers and lower dementia risk in multiple large studies.

Several specific foods and nutrients in our Alzheimer’s content cluster have direct anti-inflammatory mechanisms. Omega-3 fatty acids from fish produce specialized pro-resolving mediators that actively shut down inflammation. Our articles on fish reducing Alzheimer’s risk by 60% and fish oil preventing Alzheimer’s cover this evidence. Oleocanthal in extra virgin olive oil has anti-inflammatory potency comparable to ibuprofen. Our article Take Olive Oil Instead of Ibuprofen explores this research. Resveratrol from red wine suppresses NF-κB, a master regulator of inflammatory genes. Red Wine Cuts Alzheimer’s Risk by 45% covers the evidence.

How Frequency Therapy Addresses Chronic Inflammation

When we wrote in 2003 that “any inflammation detected should be eliminated immediately by applying the right electromagnetic frequency to the organism,” we were describing an approach that was far ahead of its time. Today, the science of bioelectromagnetic effects on inflammation is an active and growing field of research.

Frequency therapy addresses chronic inflammation through multiple mechanisms.

Targeting the Source: Pathogen Elimination

Much chronic inflammation is driven by persistent infections — organisms the immune system cannot fully clear. By applying targeted frequencies to specific pathogens, the infectious trigger of inflammation can be addressed directly. When the pathogen is eliminated, the immune system’s reason for maintaining the inflammatory response is removed, allowing the inflammation to resolve naturally.

This is fundamentally different from anti-inflammatory drugs, which suppress the inflammatory response without addressing what is causing it. Suppressing inflammation while leaving the infection in place can actually be counterproductive — the inflammation exists for a reason. The frequency approach eliminates the reason.

Supporting Resolution Pathways

Research has revealed that the resolution of inflammation is not simply the absence of pro-inflammatory signals — it is an active, coordinated process driven by specialized molecules (resolvins, protectins, maresins) and specific cellular behaviors. Frequency therapy may support these resolution pathways, helping the body complete the inflammatory cycle rather than becoming stuck in a chronic state.

Reducing Toxic Burden

Environmental toxins that drive chronic inflammation — including aluminum, heavy metals, and chemical contaminants — can be addressed through frequency protocols that support the body’s detoxification pathways. Reducing the toxic load removes a persistent inflammatory trigger.

Brain-Specific Applications

For neuroinflammation specifically, 40 Hz gamma frequency stimulation has been shown to modulate microglial behavior — shifting chronically activated microglia from their destructive state back to their protective, debris-clearing state. This is one of the most direct applications of frequency therapy to Alzheimer’s-related neuroinflammation. Our articles on 40 Hz gamma stimulation and replacing the missing gamma frequency cover this science in detail.

Chronic inflammation is the common thread running through virtually every major disease. Dr. Jeff Sutherland offers personalized paid consultations to identify the specific inflammatory triggers in your case — infections, toxins, metabolic factors — and develop a targeted frequency protocol to address them. Book Your Consultation

Practical Anti-Inflammatory Strategies You Can Start Today

While frequency therapy addresses inflammation at the electromagnetic level, several evidence-based nutritional and lifestyle strategies can reduce inflammatory burden immediately.

Nutritional Priorities

Increase omega-3 fatty acid intake through fatty fish (salmon, sardines, mackerel) at least twice per week and/or high-quality fish oil supplementation emphasizing DHA. Use extra virgin olive oil as your primary cooking and dressing fat — the oleocanthal it contains provides meaningful anti-inflammatory activity. Minimize processed foods, refined sugars, and industrial seed oils (soybean, corn, sunflower), which promote inflammatory signaling. Eat a diet rich in colorful vegetables and fruits, which provide polyphenols and antioxidants that counter oxidative stress and inflammation. Consider vitamin C supplementation, which has been shown to lower CRP levels.

Lifestyle Factors

Chronic psychological stress drives inflammation through sustained cortisol elevation and sympathetic nervous system activation. Our article Stress Equals Illness: Better Do Something About It covers the mechanisms and practical steps for managing stress-driven inflammation. Regular physical activity is one of the most potent anti-inflammatory interventions available — consistent moderate exercise reduces CRP, IL-6, and TNF-α levels. Sleep quality directly affects inflammatory markers. Chronic sleep deprivation elevates inflammatory cytokines and impairs the brain’s nightly glymphatic clearance of metabolic waste, including amyloid beta.

Frequently Asked Questions

What is the difference between acute and chronic inflammation?

Acute inflammation is the body’s healthy, short-term response to injury or infection. It produces visible signs like redness, swelling, and heat, and it resolves once the threat is eliminated. Chronic inflammation is a persistent, low-grade inflammatory state that often produces no obvious symptoms but causes cumulative damage over years and decades. Chronic inflammation is now recognized as a driving factor in heart disease, Alzheimer’s, cancer, diabetes, and many other chronic conditions. Eliminating chronic inflammation is one of the most important strategies for long-term disease prevention.

How do I know if I have chronic inflammation?

The most accessible blood test is high-sensitivity C-reactive protein (hs-CRP), which measures a key marker of systemic inflammation. Optimal levels are below 1.0 mg/L; levels above 3.0 mg/L indicate elevated inflammation and increased disease risk. Other markers including IL-6, TNF-α, and fibrinogen can be tested through specialized panels. However, chronic inflammation often exists without obvious symptoms, which is why proactive testing and preventive strategies are important even for people who feel healthy.

Can frequency therapy reduce chronic inflammation?

Frequency therapy addresses chronic inflammation through multiple pathways. Targeted frequencies can eliminate the chronic infections (viral, bacterial, parasitic) that drive persistent immune activation. Detoxification-supporting frequencies help reduce the toxic burden from environmental contaminants. Brain-specific frequencies, particularly 40 Hz gamma stimulation, have been shown to modulate microglial behavior and reduce neuroinflammation. A consultation with Dr. Jeff Sutherland can identify the specific inflammatory triggers relevant to your situation.

What foods cause the most inflammation?

The primary dietary drivers of chronic inflammation are refined sugars and high-fructose corn syrup, industrial seed oils high in omega-6 fatty acids (soybean, corn, sunflower, safflower oils), processed and ultra-processed foods, trans fats, excessive alcohol, and refined carbohydrates. Reducing or eliminating these foods while increasing anti-inflammatory foods (fatty fish, olive oil, vegetables, fruits, nuts) can produce measurable reductions in inflammatory biomarkers within weeks.

Is eliminating inflammation really more important than other health strategies?

Chronic inflammation is unique because it acts as a multiplier for virtually every other disease risk factor. Genetic predispositions, infections, toxic exposures, metabolic dysfunction, and stress all cause more damage in the presence of chronic inflammation. This is why eliminating inflammation is not just one strategy among many — it is the foundational strategy that makes every other intervention more effective. As we stated in 2003, it is the top priority for disease prevention.

Take the Next Step

Chronic inflammation is the common mechanism underlying heart disease, Alzheimer’s, cancer, and most chronic diseases. Eliminating it requires identifying and addressing the specific triggers — whether they are infections, environmental toxins, nutritional deficiencies, or metabolic dysfunction.

A consultation with Dr. Jeff Sutherland provides a comprehensive assessment of your inflammatory triggers and a personalized frequency protocol designed to address them at the source, not just suppress the symptoms.

Book Your Consultation with Dr. Jeff Sutherland

This article is part of our comprehensive Alzheimer’s resource library. Chronic neuroinflammation is a primary driver of Alzheimer’s disease progression. Read our complete guide to Alzheimer’s disease and frequency therapy for the full scope of research, from 40 Hz gamma science to infection management and personalized frequency protocols.

WIRED: What Tomorrow Holds

A Bold Prediction About the Future of Disease

In John Brockman’s book The Next Fifty Years: Science in the First Half of the Twenty-First Century (Vintage Books, 2002), evolutionary biologist Paul W. Ewald, professor of biology at Amherst College, made a prediction that caught our attention:

“Highly damaging chronic diseases — atherosclerosis, diabetes, Alzheimer’s disease, most cancers — will, in the next 50 years, be accepted as caused by infection.”

He added an honest caveat about why this acceptance would take time:

“A proportion of the old guard will have to retire or expire, and a sufficient number of young people must mature into positions of influence, to tip the balance of expert opinion.”

Why This Resonates With Our Work

When we first shared this prediction, we noted that practitioners working with frequency-based medicine had already observed the infection-disease connection that Ewald described. At the Frequency Research Foundation, Dr. Jeff Sutherland’s clinical work consistently identifies chronic infections — viral, bacterial, mycoplasmal, and parasitic — in patients with conditions that mainstream medicine classifies as non-infectious.

More than two decades into Ewald’s fifty-year timeline, the scientific evidence is moving in the direction he predicted. Research has linked herpes simplex virus to Alzheimer’s plaques, Helicobacter pylori to stomach cancer, and chronic infections to cardiovascular inflammation. The infectious theory of Alzheimer’s disease in particular has gained significant ground, with multiple pathogen types now implicated in driving the neuroinflammation and amyloid accumulation that characterize the disease.

Our Alzheimer’s research covers these connections in detail:

Alzheimer’s and Herpes Simplex Virus — HSV-1 DNA found in 90% of Alzheimer’s plaques
Mycoplasma: A Key Component in Lyme and Other Diseases — Chronic intracellular infections linked to neurodegenerative disease
Recent Research on Lyme Disease — Borrelia spirochetes recovered from Alzheimer’s brain tissue

The generational shift Ewald predicted — younger researchers open to the infectious theory, replacing an old guard invested in existing paradigms — is underway, but far from complete. The Frequency Research Foundation continues to work at this intersection, applying frequency-based protocols to the chronic infections that may underlie many of the diseases Ewald named.

Dr. Jeff Sutherland offers personalized paid consultations to assess chronic infections that may be contributing to your health challenges and develop targeted frequency protocols. Book Your Consultation

This article is part of our comprehensive Alzheimer’s resource library. The infectious theory of Alzheimer’s disease is one of the most important developments in neurodegenerative research. Read our complete guide to Alzheimer’s disease and frequency therapy for the full scope of evidence and treatment approaches.